FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992674539> ?p ?o ?g. }

• W1992674539 endingPage "201" @default.
• W1992674539 startingPage "195" @default.
• W1992674539 abstract "The purpose of this study was to assess the impact of body mass index (BMI) on clinical outcome of patients treated by percutaneous coronary intervention (PCI) using drug-eluting stents. Patients were stratified according to BMI as normal (<25 kg/m2), overweight (25 to 30 kg/m2), or obese (>30 kg/m2). At 5-year follow-up all-cause death, myocardial infarction, clinically justified target vessel revascularization (TVR), and definite stent thrombosis were assessed. A complete dataset was available in 7,427 patients, of which 45%, 22%, and 33% were classified according to BMI as overweight, obese, and normal, respectively. Mean age of patients was significantly older in those with a normal BMI (p <0.05). Incidence of diabetes mellitus, hypertension, and dyslipidemia increased as BMI increased (p <0.05). Significantly higher rates of TVR (15.3% vs 12.8%, p = 0.02) and early stent thrombosis (1.5% vs 0.9%, p = 0.04) were observed in the obese compared to the normal BMI group. No significant difference among the 3 BMI groups was observed for the composite of death/myocardial infarction/TVR or for definite stent thrombosis at 5 years, whereas the normal BMI group was at higher risk for all-cause death at 5 years (obese vs normal BMI, hazard ratio 0.74, confidence interval 0.53 to 0.99, p = 0.05; overweight vs normal BMI, hazard ratio 0.73, confidence interval 0.59 to 0.94, p = 0.01) in the multivariate Cox proportional hazard model. Age resulted in a linearly dependent covariate with BMI in the all-cause 5-year mortality multivariate model (p = 0.001). In conclusion, the “obesity paradox” observed in 5-year all-cause mortality could be explained by the higher rate of elderly patients in the normal BMI group and the existence of colinearity between BMI and age. However, obese patients had a higher rate of TVR and early stent thrombosis and a higher rate of other risk factors such as diabetes mellitus, hypertension, and hypercholesterolemia. The purpose of this study was to assess the impact of body mass index (BMI) on clinical outcome of patients treated by percutaneous coronary intervention (PCI) using drug-eluting stents. Patients were stratified according to BMI as normal (<25 kg/m2), overweight (25 to 30 kg/m2), or obese (>30 kg/m2). At 5-year follow-up all-cause death, myocardial infarction, clinically justified target vessel revascularization (TVR), and definite stent thrombosis were assessed. A complete dataset was available in 7,427 patients, of which 45%, 22%, and 33% were classified according to BMI as overweight, obese, and normal, respectively. Mean age of patients was significantly older in those with a normal BMI (p <0.05). Incidence of diabetes mellitus, hypertension, and dyslipidemia increased as BMI increased (p <0.05). Significantly higher rates of TVR (15.3% vs 12.8%, p = 0.02) and early stent thrombosis (1.5% vs 0.9%, p = 0.04) were observed in the obese compared to the normal BMI group. No significant difference among the 3 BMI groups was observed for the composite of death/myocardial infarction/TVR or for definite stent thrombosis at 5 years, whereas the normal BMI group was at higher risk for all-cause death at 5 years (obese vs normal BMI, hazard ratio 0.74, confidence interval 0.53 to 0.99, p = 0.05; overweight vs normal BMI, hazard ratio 0.73, confidence interval 0.59 to 0.94, p = 0.01) in the multivariate Cox proportional hazard model. Age resulted in a linearly dependent covariate with BMI in the all-cause 5-year mortality multivariate model (p = 0.001). In conclusion, the “obesity paradox” observed in 5-year all-cause mortality could be explained by the higher rate of elderly patients in the normal BMI group and the existence of colinearity between BMI and age. However, obese patients had a higher rate of TVR and early stent thrombosis and a higher rate of other risk factors such as diabetes mellitus, hypertension, and hypercholesterolemia." @default.
• W1992674539 created "2016-06-24" @default.
• W1992674539 creator A5013384154 @default.
• W1992674539 creator A5019587141 @default.
• W1992674539 creator A5026031312 @default.
• W1992674539 creator A5040134218 @default.
• W1992674539 creator A5041250456 @default.
• W1992674539 creator A5050827106 @default.
• W1992674539 creator A5053194091 @default.
• W1992674539 creator A5066461789 @default.
• W1992674539 creator A5076880659 @default.
• W1992674539 creator A5079151837 @default.
• W1992674539 creator A5080770746 @default.
• W1992674539 date "2011-07-01" @default.
• W1992674539 modified "2023-10-16" @default.
• W1992674539 title "Impact of Body Mass Index on the Five-Year Outcome of Patients Having Percutaneous Coronary Interventions With Drug-Eluting Stents" @default.
• W1992674539 cites W149951570 @default.
• W1992674539 cites W1974718993 @default.
• W1992674539 cites W1976248288 @default.
• W1992674539 cites W1980864783 @default.
• W1992674539 cites W1992748772 @default.
• W1992674539 cites W2007287562 @default.
• W1992674539 cites W2020606192 @default.
• W1992674539 cites W2039987373 @default.
• W1992674539 cites W2081209712 @default.
• W1992674539 cites W2082622867 @default.
• W1992674539 cites W2083697762 @default.
• W1992674539 cites W2096531477 @default.
• W1992674539 cites W2097527293 @default.
• W1992674539 cites W2101464266 @default.
• W1992674539 cites W2104599604 @default.
• W1992674539 cites W2106650290 @default.
• W1992674539 cites W2110713453 @default.
• W1992674539 cites W2111636902 @default.
• W1992674539 cites W2118411209 @default.
• W1992674539 cites W2132192300 @default.
• W1992674539 cites W2136316454 @default.
• W1992674539 cites W2145942481 @default.
• W1992674539 cites W2146056535 @default.
• W1992674539 cites W2146743728 @default.
• W1992674539 cites W2150960622 @default.
• W1992674539 cites W2155483408 @default.
• W1992674539 cites W2156848121 @default.
• W1992674539 cites W2159687614 @default.
• W1992674539 doi "https://doi.org/10.1016/j.amjcard.2011.03.023" @default.
• W1992674539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21529741" @default.
• W1992674539 hasPublicationYear "2011" @default.
• W1992674539 type Work @default.
• W1992674539 sameAs 1992674539 @default.
• W1992674539 citedByCount "36" @default.
• W1992674539 countsByYear W19926745392012 @default.
• W1992674539 countsByYear W19926745392013 @default.
• W1992674539 countsByYear W19926745392014 @default.
• W1992674539 countsByYear W19926745392015 @default.
• W1992674539 countsByYear W19926745392016 @default.
• W1992674539 countsByYear W19926745392017 @default.
• W1992674539 countsByYear W19926745392018 @default.
• W1992674539 countsByYear W19926745392019 @default.
• W1992674539 countsByYear W19926745392020 @default.
• W1992674539 countsByYear W19926745392021 @default.
• W1992674539 crossrefType "journal-article" @default.
• W1992674539 hasAuthorship W1992674539A5013384154 @default.
• W1992674539 hasAuthorship W1992674539A5019587141 @default.
• W1992674539 hasAuthorship W1992674539A5026031312 @default.
• W1992674539 hasAuthorship W1992674539A5040134218 @default.
• W1992674539 hasAuthorship W1992674539A5041250456 @default.
• W1992674539 hasAuthorship W1992674539A5050827106 @default.
• W1992674539 hasAuthorship W1992674539A5053194091 @default.
• W1992674539 hasAuthorship W1992674539A5066461789 @default.
• W1992674539 hasAuthorship W1992674539A5076880659 @default.
• W1992674539 hasAuthorship W1992674539A5079151837 @default.
• W1992674539 hasAuthorship W1992674539A5080770746 @default.
• W1992674539 hasConcept C126322002 @default.
• W1992674539 hasConcept C141071460 @default.
• W1992674539 hasConcept C164705383 @default.
• W1992674539 hasConcept C207103383 @default.
• W1992674539 hasConcept C2778096610 @default.
• W1992674539 hasConcept C2778583881 @default.
• W1992674539 hasConcept C2780221984 @default.
• W1992674539 hasConcept C2780400711 @default.
• W1992674539 hasConcept C2780586474 @default.
• W1992674539 hasConcept C2781223611 @default.
• W1992674539 hasConcept C44249647 @default.
• W1992674539 hasConcept C45393284 @default.
• W1992674539 hasConcept C500558357 @default.
• W1992674539 hasConcept C511355011 @default.
• W1992674539 hasConcept C71924100 @default.
• W1992674539 hasConceptScore W1992674539C126322002 @default.
• W1992674539 hasConceptScore W1992674539C141071460 @default.
• W1992674539 hasConceptScore W1992674539C164705383 @default.
• W1992674539 hasConceptScore W1992674539C207103383 @default.
• W1992674539 hasConceptScore W1992674539C2778096610 @default.
• W1992674539 hasConceptScore W1992674539C2778583881 @default.
• W1992674539 hasConceptScore W1992674539C2780221984 @default.
• W1992674539 hasConceptScore W1992674539C2780400711 @default.
• W1992674539 hasConceptScore W1992674539C2780586474 @default.
• W1992674539 hasConceptScore W1992674539C2781223611 @default.
• W1992674539 hasConceptScore W1992674539C44249647 @default.

• next